Tag - Respiratory Motion

Respiratory Motion, Inc. is excited to announce FDA clearance for use of the ExSpiron™ 1Xi Minute Ventilation Monitor in Pediatric Patients

Respiratory Motion, Inc. reported today that FDA clearance was received for the newest version of its ExSpiron Minute Ventilation (MV) monitoring system on Friday March 16th and announced its plan to launch the new ExSpiron at the Society for Pediatric Anesthesia-American Academy of Pediatrics in Phoenix, March 23-25. Read more >>

Respiratory Motion, Inc. and Corestone Biosciences (Beijing) Co., Ltd., have established a Joint Venture Company to deliver monitoring solutions to Chinese healthcare market and the globe

Respiratory Motion, Inc. (Waltham, Massachusetts, USA) the global leader in minute ventilation monitoring and Corestone Biosciences Co., Ltd., an innovative medical device company in anesthesia and analgesia headquartered in Beijing, China have entered into an agreement to form a Joint Venture Company (JV). The JV will offer a new generation of Respiratory Volume Monitors based on Respiratory Motion’s ExSpiron platform, along with other novel critical care solutions for hospital and home markets. The JV will operate out of Zhengzhou […]

Respiratory Motion Inc., is excited to announce the launch of the latest ExSpiron 1Xi™ Respiratory Monitor

Respiratory Motion, Inc., announced today its plans to launch the newest version of its ExSpiron 1Xi™ Minute Ventilation (MV) Monitor at the American Society of Anesthesiologists (ASA) in Boston, October 21-25 following recent FDA 510(k) clearance. This new ExSpiron requires no calibration, which greatly expands its range of use. Physicians, nurses, respiratory therapists, EMT’s and first responders can now easily assess and measure a patients breathing in seconds. Read more >>